Ipratropium Bromide 42 ug/1 (Ipratropium Bromide SPRAY) 42 ug/1

Ipratropium bromide is an anticholinergic medication that blocks the action of acetylcholine on muscarinic receptors in the nasal mucosa. By doing so, it reduces the production of mucus in the nasal glands, which helps to decrease nasal secretions and alleviate symptoms of a runny nose. Its targeted action helps to dry up the nasal passages without affecting the sense of smell or causing drowsiness.

The usual dose of Ipratropium Bromide 42 µg/1 is determined by a healthcare provider based on the condition being treated. For the common cold, it is typically used as 2 sprays in each nostril 3 to 4 times a day. For seasonal allergic rhinitis, it is usually 2 sprays in each nostril 4 times a day. For perennial rhinitis, it is 2 sprays in each nostril 2 to 3 times a day.

Ipratropium bromide is classified as a pregnancy category C medication, meaning that it should be used during pregnancy only if the potential benefits outweigh the risks. It is not known whether ipratropium bromide is excreted in human milk. Women who are pregnant or breastfeeding should consult their healthcare provider before using this medication.

To order Ipratropium Bromide 42 µg/1 from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the import paperwork.

Ipratropium bromide is different from other nasal decongestants because it specifically targets the mucus-producing glands in the nasal passages. Unlike decongestants, which shrink blood vessels to reduce congestion, ipratropium bromide reduces the production of mucus, making it particularly effective for a runny nose. It does not relieve nasal congestion, sneezing, or postnasal drip, so it is often used in combination with other medications for comprehensive symptom relief.

Ipratropium Bromide 42 µg/1 should be stored at room temperature away from moisture and heat. Keep the cap tightly closed when not in use. Do not allow the medicine to freeze. Proper storage ensures the medication remains effective and safe to use.

Ipratropium Bromide 42 µg/1 is administered as a nasal spray. Gently blow your nose before using the medication. Spray the medication into the nose as directed by your healthcare provider, usually 3 or 4 times a day in each nostril. Avoid spraying it in your eyes, as it can cause blurred vision or eye pain.

The most serious risks associated with Ipratropium Bromide include blurred vision or eye pain if the spray gets into the eyes, which can potentially trigger an acute attack of narrow-angle glaucoma. Severe nasal irritation or ulceration and allergic reactions such as rash, itching, or swelling are also possible. If you experience any of these symptoms, seek medical advice immediately.

Ipratropium Bromide 42 µg/1 should not be used by individuals who are allergic to ipratropium bromide or any of the other ingredients in the medication. It should be used with caution in patients with narrow-angle glaucoma, urinary retention, or severe heart conditions. Always consult a healthcare provider before using this medication, especially if you have any pre-existing medical conditions or are taking other medications.